The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1053-2498(01)00289-3PMID 11557189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanical Circulatory Support for Advanced Heart Failure: Effect of Patient Selection on Outcome

  2001cited by this paper
• Integrin Dependence of Brain Natriuretic Peptide Gene Promoter Activation by Mechanical Strain*

  2000cited by this paper
• Mechanical Circulatory Support : A Potential Mechanism for Cardiac Recovery in Failing Human Myocardium After α Decreased Expression of Tumor Necrosis Factor

  1999cited by this paper
• Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

  1999cited by this paper
• Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism.

  1999cited by this paper
• Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure.

  1999cited by this paper
• Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy--first results of the Halle Assist Induced Recovery Study (HAIR).

  1999cited by this paper
• Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure.

  1998cited by this paper
• Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy.

  1997cited by this paper
• Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II

  1997cited by this paper
• Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure.

  1996cited by this paper
• Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

  1996cited by this paper
• Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure.

  1996cited by this paper
• Mechanical circulatory support: the Bad Oeynhausen experience.

  1995cited by this paper
• Mechanical circulatory support: The Bad Oeynhausen experience

  1995cited by this paper
• Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

  1994cited by this paper
• Natriuretic peptide system in human heart failure.

  1993cited by this paper
• Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro.

  1993cited by this paper
• Stretch-induced atrial natriuretic factor release utilizes a rapidly depleting pool of newly synthesized hormone.

  1993cited by this paper
• Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure

  1993cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation.

  1990cited by this paper
• Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.

  1988cited by this paper

• A two-centre study investigating the association between brain natriuretic peptides & outcomes in continuous flow left ventricular assist device recipients

  2025cites this paper
• Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence

  2022cites this paper
• Biology of myocardial recovery in advanced heart failure with long-term mechanical support.

  2022cites this paper
• Prognostic Implications of Ambulatory N-Terminal Pro-B-Type Natriuretic Peptide Changes in Patients with Continuous-Flow Left Ventricular Assist Devices

  2021cites this paper
• The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation.

  2020cites this paper
• Biomarkers in Advanced Heart Failure

  2020cites this paper
• Extracorporeal Membrane Oxygenation and Renal Function

  2019cites this paper
• Natriuretic Peptides in Clinical Practice.

  2019cites this paper
• Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients.

  2019cites this paper
• Postoperative B-Type Natriuretic Peptide as Predictor for Postoperative Outcomes in Patients Implanted With Left Ventricular Assist Devices

  2019cites this paper
• The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery

  2018cites this paper
• Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.

  2017cites this paper
• Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017; 161:XX

  2017cites this paper
• Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling.

  2016cites this paper
• Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.

  2015cites this paper
• Serum Brain Natriuretic Peptide Concentration 60 Days After Surgery as a Predictor of Long-Term Prognosis in Patients Implanted With a Left Ventricular Assist Device

  2015cites this paper
• Galectin-3 in Cardiovascular Disease

  2015cites this paper
• Serum Brain Natriuretic Peptide Concentration 60 Days After Surgery as a Predictor of Long-Term Prognosis in Patients Implanted With a Left Ventricular Assist Device

  2015cites this paper
• Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.

  2015cites this paper
• Myocardial recovery: a focus on the impact of left ventricular assist devices

  2014cites this paper
• Biomarkers in mechanical circulatory support.

  2014cites this paper
• The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP.

  2012cites this paper
• Myocardial Recovery With Left Ventricular Assist Devices

  2012cites this paper
• Adipose Tissue Biology and Cardiomyopathy: Translational Implications

  2012cites this paper
• Cellular, Molecular, Genomic, and Functional Changes That Occur in the Failing Heart in Response to Mechanical Circulatory Support

  2012cites this paper
• Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.

  2012cites this paper
• Novel biomarkers in human terminal heart failure and under mechanical circulatory support

  2011cites this paper
• The influence of operational protocol on the fluid dynamics in the 12 cc Penn state pulsatile pediatric ventricular assist device: the effect of end-diastolic delay.

  2010cites this paper
• Elevated B-type natriuretic peptide without volume overload in a left ventricular assist device patient with a subdural hematoma.

  2010cites this paper
• The use of mechanical circulatory support and passive ventricular constraint in patients with acute and chronic heart failure

  2010cites this paper
• Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

  2010cites this paper
• The use of mechanical circulatory support and passive ventricular constraint in patients with acute and chronic heart failure

  2010cites this paper
• CARDIOGENIC SHOCK

  2010cites this paper
• Increased number of circulating progenitor cells after implantation of ventricular assist devices.

  2009cites this paper
• Initial Results of Clinical Trial with a New Left Ventricular Assist Device (LVAD) Providing Synchronous Pulsatile Flow

  2009cites this paper
• Mechanical unloading and β2-adrenoceptor stimulation for the treatment of heart failure.

  2009cites this paper
• Left ventricular assist device-induced molecular changes in the failing myocardium

  2008cites this paper
• Biomarker responses during mid-term mechanical cardiac support in children.

  2008cites this paper
• Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.

  2008cites this paper
• Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.

  2008cites this paper
• Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.

  2008cites this paper
• Current and future considerations in the use of mechanical circulatory support devices.

  2008cites this paper
• Elevated Afterload, Neuroendocrine Stimulation, and Human Heart Failure Increase BNP Levels and Inhibit Preload-Dependent SERCA Upregulation

  2008cites this paper
• Patients who have dilated cardiomyopathy must have a trial of bridge to recovery (pro).

  2007cites this paper
• Avaliação do emprego clínico do dispositivo de assistência ventricular InCor como ponte para o transplante cardíaco

  2007cites this paper
• Selective upregulation of β1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices

  2006cites this paper
• Left Ventricular Assist Device Weaning: Hemodynamic Response and Relationship to Stroke Volume and Rate Reduction Protocols

  2006cites this paper
• Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.

  2006cites this paper
• Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.

  2006cites this paper
• LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery.

  2006cites this paper
• Relevance of Brain Natriuretic Peptide in Preload-Dependent Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ ATPase Expression

  2006cites this paper
• Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.

  2006cites this paper
• Differential exercise performance on ventricular assist device support.

  2005cites this paper
• Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.

  2005cites this paper
• Myocardial Recovery Using Ventricular Assist Devices: Prevalence, Clinical Characteristics, and Outcomes

  2005cites this paper
• Reloading the heart: a new animal model of left ventricular assist device removal.

  2005cites this paper
• The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.

  2004cites this paper
• Weaning of rotary blood pump recipients after myocardial recovery: a computer study of changes in cardiac energetics.

  2004cites this paper
• B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device.

  2004cites this paper
• Ventricular assist devices

  2003cites this paper
• Mechanical unloading increases caveolin expression in the failing human heart.

  2003cites this paper
• Differential regulation of Ca2+-dependent ATPase-activity in left ventricular myocardium during mechanical circulatory support.

  2003cites this paper